Fri, 13 Nov 2026

Suvoda expands software and services to support patient retention in trials

Image by Subhash Chaudhary from Pixabay

Suvoda has introduced new features in Greenphire Travel, its platform designed to reduce logistical barriers to clinical trial participation.

Greenphire Travel now offers sponsors and CROs expanded travel support options, improved visibility into travel costs and trip status, and a simplified travel experience for patients.

Elizabeth Smith
Elizabeth Smith

“Participants in clinical trials are often managing serious illness on top of the logistical demands of getting to visits. Greenphire Travel removes the coordination burden from sites and their patients so they can focus on what matters—their health and wellbeing,” said Elizabeth Smith, director of Product Management, Patient Experience at Suvoda.

Expanded Greenphire Travel

Greenphire Travel now provides global rideshare and car services, including Lyft, Uber Health, and Bolt, depending on the region. Participants can book rides through the Suvoda App and access information on flights, hotels, rideshare status, study appointments, questionnaires, and payments.

Sites benefit from a more intuitive travel request workflow, clearer trip status updates, and secure messaging. Sponsors and CROs receive detailed reporting for greater visibility into travel spending and policy compliance across global trials.

Greenphire Travel offers expert global support through two delivery models:

  • The site-led option lets study teams submit straightforward travel requests directly.
  • The Concierge model delivers personalised coordination for complex studies and participant needs, with coordinators based in over 40 countries and available 24/7 throughout the trial.
Will Wing
Will Wing

“Clinical trials vary enormously in complexity, and the travel support behind them should too,” said Will Wing, director of Product at Suvoda.

Related:  Latest IBM Bob updates to help enterprises deliver production-ready software

Related Stories

MORE STORIES

Subscribe